| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Atlas Venture Associates Ix, L.P. serves as a 10% Owner at NTLA. Across recent SEC filings that breaks down to 0 buys and 2 sells.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2017 | NTLA Intellia Therapeutics, Inc. | 10% Owner | Sell | 21,132 | $13.91 | $293,842.63 | -79.3% |